1. Antibiotics Development and the Emergence of Resistance: Clinical Pharmacology to the Rescue. (12th January 2018) Authors: Upreti, Vijay V.; Barbour, April M. Journal: Journal of clinical pharmacology Issue: Volume 58:Number 4(2018) Page Start: 409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors. Issue 1 (25th September 2018) Authors: Tran, Ben; Carvajal, Richard D.; Marabelle, Aurelien; Patel, Sandip Pravin; LoRusso, Patricia M.; Rasmussen, Erik; Juan, Gloria; Upreti, Vijay V.; Beers, Courtney; Ngarmchamnanrith, Gataree; Schöffski, Patrick Journal: Journal for immunotherapy of cancer Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects. (December 2013) Authors: Upreti, Vijay V.; Wang, Jessie; Barrett, Yu Chen; Byon, Wonkyung; Boyd, Rebecca A.; Pursley, Janice; LaCreta, Frank P.; Frost, Charles E. Journal: British journal of clinical pharmacology Issue: Volume 76:Number 6(2013:Dec.) Page Start: 908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Exodus of clinical pharmacologists and pharmacometricians from academia—Who is to blame? A policy statement from the American College of Clinical Pharmacology. (2nd July 2015) Authors: Upreti, Vijay V.; for the Public Policy Committee of the American College of Clinical Pharmacology Journal: Journal of clinical pharmacology Issue: Volume 55:Number 9(2015:Sep.) Page Start: 955 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Industrial Perspective on the Benefits Realized From the FDA's Model‐Informed Drug Development Paired Meeting Pilot Program. Issue 5 (15th May 2021) Authors: Galluppi, Gerald R.; Brar, Satjit; Caro, Luzelena; Chen, Yuan; Frey, Nicolas; Grimm, Hans Peter; Rudd, Deanne Jackson; Li, Chi‐Chung; Magee, Mindy; Mukherjee, Arnab; Nagao, Lee; Purohit, Vivek S.; Roy, Amit; Salem, Ahmed Hamed; Sinha, Vikram; Suleiman, Ahmed A.; Taskar, Kunal S.; Upreti, Vijay V.... Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 5(2021) Page Start: 1172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Meta‐analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling. (9th October 2015) Authors: Upreti, Vijay V.; Wahlstrom, Jan L. Journal: Journal of clinical pharmacology Issue: Volume 56:Number 3(2016) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Model‐Based Meta‐Analysis: Optimizing Research, Development, and Utilization of Therapeutics Using the Totality of Evidence. Issue 5 (14th June 2019) Authors: Upreti, Vijay V.; Venkatakrishnan, Karthik Journal: Clinical pharmacology & therapeutics Issue: Volume 106:Issue 5(2019) Page Start: 981 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Oncolytic viral kinetics mechanistic modeling of Talimogene Laherparepvec (T‐VEC) a first‐in‐class oncolytic viral therapy in patients with advanced melanoma. (11th January 2023) Authors: Ahamadi, Malidi; Kast, Johannes; Chen, Po‐Wei; Huang, Xiaojun; Dutta, Sandeep; Upreti, Vijay V. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 12:Number 2(2023) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective. Issue 2 (30th December 2020) Authors: Heimbach, Tycho; Chen, Yuan; Chen, Jun; Dixit, Vaishali; Parrott, Neil; Peters, Sheila Annie; Poggesi, Italo; Sharma, Pradeep; Snoeys, Jan; Shebley, Mohamad; Tai, Guoying; Tse, Susanna; Upreti, Vijay V.; Wang, Ying‐Hong; Tsai, Alice; Xia, Binfeng; Zheng, Ming; Zhu, Andy Z.X.; Hall, Stephen Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 2(2021) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T‐cellular therapy development. Issue 9 (2nd July 2022) Authors: Kast, Johannes; Nozohouri, Saeideh; Zhou, Di; Yago, Marc R.; Chen, Po‐Wei; Ahamadi, Malidi; Dutta, Sandeep; Upreti, Vijay V. Journal: Clinical and translational science Issue: Volume 15:Issue 9(2022) Page Start: 2057 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗